Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Raul R. Rodriguez

Raul R. Rodriguez is recorded as CEO and Board Member at Rigel Pharmaceuticals Inc (RIGL). Rigel Pharmaceuticals Inc reported in an 8-K filed May 30, 2023 that Raul R. Rodriguez was appointed Director, effective May 25, 2023. The proxy statement of Rigel Pharmaceuticals Inc reports total compensation of $2,998,688 for Raul R. Rodriguez in fiscal 2024, including a base salary of $757,000. Disclosed compensation is on record for 7 fiscal years.

“Each of the three nominees for director, to serve until the Company's 2026 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified, was elected as follows:”
Rigel Pharmaceuticals Inc Form 8-K, filed May 30, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Rigel Pharmaceuticals Inc

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Rigel Pharmaceuticals Inc (RIGL) $757,000 $2,998,688
2023 Rigel Pharmaceuticals Inc (RIGL) $728,000 $3,440,790
2022 Rigel Pharmaceuticals Inc (RIGL) $700,000 $2,864,120
2020 Rigel Pharmaceuticals Inc (RIGL) $662,256 $2,963,884
2019 Rigel Pharmaceuticals Inc (RIGL) $649,271 $2,562,118
2018 Rigel Pharmaceuticals Inc (RIGL) $636,540 $3,980,860
2017 Rigel Pharmaceuticals Inc (RIGL) $618,000 $2,172,790

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.